Portage Biotech (PRTG) Institutional Ownership → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free PRTG Stock Alerts $0.28 -0.02 (-5.79%) (As of 01:43 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Portage Biotech (NASDAQ:PRTG)CurrentInstitutional OwnershipPercentage13.36%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$4.98MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$167.44K Get PRTG Insider Trade Alerts Want to know when executives and insiders are buying or selling Portage Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PRTG Institutional Buying and Selling by Quarter Ad American Hartford Gold GroupTrump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE Portage Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC1,876,105$3.42M0.0%-4.7%10.540% 11/15/2023Armistice Capital LLC1,968,105$4.11M0.1%N/A11.056% 8/14/2023Bison Wealth LLC213,398$746K0.1%N/A1.199% 8/8/2023Ieq Capital LLC16,650$58K0.0%N/A0.094% 5/10/2023MAI Capital Management78,676$243K0.0%+36.8%0.464% 2/9/2023MAI Capital Management57,512$304K0.0%N/A0.340% Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Ergoteles LLC20,597$140K0.0%-11.6%0.122% 7/21/2022Beacon Investment Advisory Services Inc.11,395$80K0.0%N/A0.085% 5/2/2022 Allspring Global Investments Holdings LLC8,189$53K0.0%N/A0.061% 4/20/2022 Sigma Planning Corp11,388$75K0.0%N/A0.085% 2/14/2022Maven Securities LTD131,832$1.42M0.0%-41.3%0.989% 2/4/2022Beacon Investment Advisory Services Inc.11,395$122K0.0%N/A0.086% 11/9/2021BlackRock Inc.213,123$4.33M0.0%+19.7%1.599% 11/4/2021Deutsche Bank AG2,875$58K0.0%+34.3%0.022% 8/18/2021Blackstone Inc65,000$1.36M0.0%N/A0.488% 8/16/2021Blackstone Inc65,000$1.36M0.0%N/A0.488% 8/16/2021California State Teachers Retirement System5,050$106K0.0%N/A0.038% 8/16/2021Maven Securities LTD278,694$6.33M0.3%N/A2.091% 8/16/2021State Street Corp46,453$974K0.0%N/A0.349% 8/13/2021Northern Trust Corp44,634$935K0.0%N/A0.335% 8/13/2021Altium Capital Management LP75,000$1.57M0.4%N/A0.563% 8/13/2021Geode Capital Management LLC35,039$734K0.0%N/A0.263% 8/13/2021Vanguard Group Inc.13,107$275K0.0%N/A0.098% 8/12/2021JPMorgan Chase & Co.4,746$99K0.0%N/A0.036% 8/12/2021Monashee Investment Management LLC110,000$2.31M0.3%N/A0.825% 8/11/2021BlackRock Inc.178,027$3.73M0.0%N/A1.336% 8/11/2021Deutsche Bank AG2,140$45K0.0%N/A0.016% 8/2/2021 New York State Common Retirement Fund3,900$82K0.0%N/A0.032% 5/21/2021Beacon Investment Advisory Services Inc.11,395$319K0.0%N/A0.094% (Data available from 1/1/2016 forward) PRTG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PRTG shares? During the previous two years, the following institutional investors and hedge funds held shares of Portage Biotech shares: Armistice Capital LLC ($3.42M), Bison Wealth LLC ($746K), MAI Capital Management ($243K), Ergoteles LLC ($140K), and Beacon Investment Advisory Services Inc. ($80K), Ieq Capital LLC ($58K).Learn more on PRTG's institutional investors. What percentage of Portage Biotech stock is owned by institutional investors? 13.36% of Portage Biotech stock is owned by institutional investors. Learn more on PRTG's institutional investor holdings. Which institutional investors have been buying Portage Biotech stock? The following institutional investors have purchased Portage Biotech stock in the last 24 months: Armistice Capital LLC ($1.97M), Bison Wealth LLC ($213.40K), MAI Capital Management ($78.68K), Ieq Capital LLC ($16.65K), and Beacon Investment Advisory Services Inc. ($11.40K). How much institutional buying is happening at Portage Biotech? Institutional investors have bought a total of 2,288,224 shares in the last 24 months. This purchase volume represents approximately $5.37M in transactions. Which Portage Biotech major shareholders have been selling company stock? The following institutional investors have sold Portage Biotech stock in the last 24 months: Armistice Capital LLC ($92K), and Ergoteles LLC ($2.71K). How much institutional selling is happening at Portage Biotech? Institutional investors have sold a total of 94,706 shares in the last 24 months. This volume of shares sold represents approximately $185.89K in transactions. Related Companies: Ensysce Biosciences Major Shareholders Genprex Major Shareholders Longeveron Major Shareholders SunLink Health Systems Major Shareholders Bright Minds Biosciences Major Shareholders Sharps Technology Major Shareholders Acutus Medical Major Shareholders Venus Concept Major Shareholders Exicure Major Shareholders IMAC Major Shareholders This page (NASDAQ:PRTG) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.